 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Apr 01, 2021 |
| Title |
Superior production of heavy pamamycin derivatives using a bkdR null mutant of Streptomyces albus J1074/R2 |
| Organism |
Streptomyces albidoflavus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Background: Pamamycins macrodiolides of polyketide origin which form a family of differently large homologues with molecular weights between 579 and 663. They offer promising biological activity against pathogenic fungi and gram-positive bacteria. Admittedly, production titers are still low and pamamycins are typically formed as crude mixture which mainly contains smaller derivatives. Therefore, strategies that enable a more efficient production of pamamycins with increased fractions of the rare large derivatives are highly desired. Here we took a systems biology approach, integrating transcription profiling by RNA sequencing and intracellular metabolite analysis to enhance pamamycin production in the heterologous host S. albus J1074/R2.
Results: Supplemented with L-valine, the recombinant pamamycin producer revealed a threefold increased pamamycin titer of about 3.5 mg L-1 and elevated fractions of larger derivatives: Pam 649 was strongly increased, and Pam 663 was newly formed. These beneficial effects were driven by increased availability of intracellular CoA esters, the building blocks for the polyketide, resulting from L-valine catabolism. Unfavorably, the presence of L-valine impaired growth of the strain, repressed genes of mannitol uptake and glycolysis, and suppressed pamamycin formation, despite the biosynthetic gene cluster was activated, restricting production to the post L-valine phase. A null mutant of the transcriptional regulator bkdR, controlling a branched-chain amino acid dehydrogenase complex, revealed decoupled pamamycin biosynthesis and accumulated the polyketide independent of the nutrient status. Supplemented with L-valine, the regulator mutant enabled the biosynthesis of pamamycin mixtures with up to 55% of the heavy derivatives Pam 635, Pam 649, and Pam 663, almost 20-fold more than the wild type.
Conclusions: Our findings open the door to provide rare heavy pamamycins at markedly increased efficiency and facilitate studies to assess their specific biological activities and explore this important polyketide further.
|
| |
|
| Overall design |
Whole transcriptomes of a pamamycin production strain derived from two time points (growth and production phase), two treatments (+/- valine), and two strains (wildtype and Delta-bkdR) using 3 biological replicates each.
|
| |
|
| Contributor(s) |
Gläser L, Kuhl M, Stegmüller J, Rückert C, Kalinowski J, Luhetskyy A, Wittmann C |
| Citation(s) |
34082758 |
| |
| Submission date |
Mar 09, 2021 |
| Last update date |
Jun 09, 2021 |
| Contact name |
Christian Ruckert-Reed |
| E-mail(s) |
[email protected]
|
| Phone |
+49 521 106 86308
|
| Organization name |
Bielefeld University
|
| Department |
Medical School OWL
|
| Lab |
CF Omics NGS
|
| Street address |
Sequenz 1
|
| City |
Bielefeld |
| ZIP/Postal code |
33615 |
| Country |
Germany |
| |
|
| Platforms (1) |
| GPL29830 |
Illumina NextSeq 500 (Streptomyces albidoflavus) |
|
| Samples (18)
|
|
| Relations |
| BioProject |
PRJNA708335 |
| SRA |
SRP310009 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE168592_RAW.tar |
670.0 Kb |
(http)(custom) |
TAR (of TXT) |
| GSE168592_Raw_Read_Count_Matrix.txt.gz |
225.1 Kb |
(ftp)(http) |
TXT |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data provided as supplementary file |
| Processed data are available on Series record |
|
|
|
|
 |
Less...
More...